Central single and chronic administration of morphine stimulates corticosterone and interleukin (IL)-6 in adjuvant-induced arthritis

Journal of Physiology and Pharmacology

Volumn 51, Issue 4, 2000, Pages 897-906

  Zubelewicz, B ^a   Muc Wierzgon M ^a   Harbuz, M S ^b   Brodziak, A ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Adiuvant arthritis; Corticosterone; Interleukin 6; Morphine

Indexed keywords

CORTICOSTERONE; INTERLEUKIN 6; MORPHINE; NARCOTIC ANALGESIC AGENT; SODIUM CHLORIDE;

ADJUVANT ARTHRITIS; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIND PAW; MALE; NONHUMAN; RAT; ANIMAL; ARTHRITIS; BLOOD; DRUG ADMINISTRATION; HINDLIMB; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; RAT STRAIN; REFERENCE VALUE;

ANALGESICS, OPIOID; ANIMALS; ARTHRITIS, EXPERIMENTAL; CORTICOSTERONE; DRUG ADMINISTRATION SCHEDULE; HINDLIMB; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-6; MALE; MORPHINE; RATS; RATS, INBRED STRAINS; REFERENCE VALUES; SODIUM CHLORIDE;

EID: 0034568984     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Harbuz MS, Lightman SL. Stress and the hypothalamo-pituitary-adrenal axis: acute and Immunological activation. J Endocrinol 1992; 134: 327-339.
2. Harbuz MS, Rees RG, Fekland D, Jessop DS, Brewerton D, Lightman SL. Paradoxical response of hypothalamic CRF mRNA and CRF-41 peptide and adenophyscal POMC mRNA during chronic inflammatory stress. Endocrinololy 1992; 130: 1394-1400.
3. Harbuz MS, Rocs RG, Lightman SL. Hypothalamo-pituitary responses to acutc stress and changes in circulating glucocorticoids during chronic adjuvant-induced arthritis in the rat. J Physiol 1993; 264: R179-185.
4. Sarlis NJ, Chowdrey HS, Stcphanou A, Lightman SL. Chronic activation of the hypothalamo-pituitary-adrenal axis and loss of the circadian rhythm during adjuvant-induced arthritis in the rat. Endocrinololy 1992; 130: 1775-1779.
5. Sarlis NJ, Stcphanou A, Knight RA, Lightmann SL, Chowdrey HS. Effects of glucucorticoids and chronic inflammatory stress upon anterior pituitary intcrlcukin-6 mRNA expression in the rat. Bril J Rheumatol 1993; 32: 653-657.
6. Chowdrey HS, Larsen PJ, Harbuz MS, Jessop DS, Aguilera G, Eckland DJA, Lightman SL. Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induccd arthritis. Brit J Pharmacol 1995; 116: 2417-1424.
7. Harbuz MS. Conde GL, Marti O, Lightman SL, Jessop DS. The hypothalamic-pituitary-adrenal axis in autoimmunity. Ann NY Acad Sci 1997; 823: 243-246.
8. Muramani N, Fukata J, Tsukada T, et al. Bacterial lipopolisaccharide-induced expression of Interleukin-6 messenger RNA in the rat hypothalamus, pituitary, adrenal gland and spleen. Endocrinology 1993; 33: 2574-2578.
9. Gadient RA, Otten U. Identification of interleukin-6 (IL-6) expressing neurons in the ccrebellum and hippocampus of normal adult rats. Neurosci lett 1995; 194: 17-20.
10. Mihara M, Ikuta M, Koishihara K., Ohsugi Y. IL-6 inhibits dclayed-type hypersensitivity and the development of adjuvant arthritis. J Immunol 1991; 21: 2327-2331.
11. De Simoni MG, Del Bo R. De Luigi A, Simard S, Forloni G. Central endotoxin induces different patterns of IL-I beta and IL-6 mRNA expression and IL-6 secretion in the brain and periphery. Endocrinology 1995; 136: 897-902.
12. Shinmei M, Masuda K, Kikuchi T, Shinomura Y. Interleukin-1, TNF alpha and IL-6 as mediators of cartilage destruction. Semin Arth Rheum 1989; 18: 27-31.
13. De Simoni MG, Sironi M, De Luigi A, Manfridi A, Mantovani A, Ghezzi P. Intracerebroventricular injection of interleukin-1 induces high circulating levels of inlerleukin-6. J Exp Med 1990; 171: 1773-1778.
14. Bertolucci M, Perego C, De Simoni MG. Central opiate modulation on peripheral IL-6 in rats. Neuroreport 1996; 7: 1181-1184.
15. Zubclcwicz B, Braczkowski R. Renshaw D, Harbuz MS. Central injection of morphine stimulates plasma corticostcronc and interleukin (IL)-6 and IL-6r mRNAs in the pituitary and adrenals in adjuvant-induccd arthritis. J Biol Reg Homeost Ag 1999; 13: 103-9.
16. Harbuz MS, Lightmann SL. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat. J Endocrinol 1989; 122: 705-711.
17. Chikanza IC, Chrousos G, Panayi GS. Abnormal neuroendocrine immune communications in patients with rheumatoid arthritis. Eur J Clin Invest 1992; 22: 635-637.
18. Bcrtini R, Bianchi M, Ghezzi P. Adrenalectomy sentitizes mice to the lethal effect ol interleukin-1 and tumour necrosis factor. J Exp Med 1988; 167: 1708-1712.
19. Bhattacharya SK, Saraswati M. Sen AP. Effect of centrally administered enkephalins on carageenin-induced paw oedema in rats. Rev Exp Med 1992; 192: 443-449.
20. Walker JS, Chandler AK, Wilson JI, Binder W, Day RO. Effect of mu-opioids morphine and buprenorphine on the development of adjuvant arthritis in rats. Inflamm Res 1996; 45: 557-563.
21. Earl JR. Claxson AW, Blake DR, Morris CJ. Proinflammatory effects of morphine in the rat adjuvant arthritis model. Int J Tissue React 1994; 182: 17-20.
22. Lcisten JC., Gaarde WA, Scholtz W. Intcrlcukin-6 serum levels correlate with foot-pad swelling in adjuvant-induced arthritic Lewis rats treated with cyclosporinA and indomethacin. Clin Immunol Immunopathol 1990, 56: 108-115.
23. Ianaro A, Xu D, O’Donnell CA, Di Rosa M, Liew FY. Expression of TGFβ in attenuated Salmonella typhimurium: oral administration leads to the reduction of inflammation, IL-2 and IFNγ, but enhancement of IL-10, in carragecnin-induced oedema in mice. Immunology 1995; 84: 8-15.
24. Chao CC, Hu TW, Zhou Y, Murtaugh MP. Tsang M, Peterson PK. Morphine potentiates Transforming Growth Factor-β release from human peripheral blood mononuclear cell cultures. J Pharmacol Exp Ther 1992; 278: 19-24.
25. Chemajovsky Y, Adams G, Triantaphyllopoulos K. Ledda MF, Podhajcer OL. Pathogenic lymphoid cells engineered to express TGF beta 1 ameliorate disease in a collagen-induced arthritis model. Gene Ther 1997; 4: 553-559.
26. Scott M, Carr DJ. Morphine suppresses the alloanligcn-driven CTL response in a dose-dependent and naltrexone reversible manner. J Pharmacol Exp Ther 1996; 278: 980-8.
27. Joosten LA, Lubberts E, Durcz P, Hclsen MM, Jacobs MJ, Goldman M, ven der Berg WB Role of IL-4 and IL-10 in murine collagen-induced arthritis. Protective effect of IL-4 and IL-10 treatment in cartilage destruction. Arthritis Rheum 1997; 40: 249-260.